Investing
LetsGetChecked plans to roll out new care pathways for patients with ailments and chronic conditions.
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.
The Nashville-based company partners with health plans to offer their members a range of renal care services.
The company plans to use the new money to grow out its business and sales team.
Also: Phil scores $100 million for its prescription refill platform and Synchron rakes in $40 million.
The health startup provides telemedicine services for insurance companies, corporations and government entities.
The deal is expected to close in the second half of 2021 and be worth roughly $4.2 billion.
With this raise, in addition to Nayya’s Series A round from earlier this year, the company has raised nearly $50 million to date.
Frost & Sullivan says the recent shift in attention away from primarily focusing on reproductive-age issues to untapped market areas will be a key factor to the sector’s growth.
The investment will support the development of Ada's symptom assessment and care navigation platform.